阿德福韦酯联合苦参碱治疗乙型肝炎的疗效分析

United adefovir dipivoxil and matrine treatment efficacy analysis of hepatitis B

目的探讨阿德福韦酯联合苦参碱治疗乙型肝炎患者的疗效。方法将96例患者随机分为3组,1组为阿德福韦酯单独治疗组,32例,2组为苦参碱单独治疗组,32例,3组为阿德福韦酯与苦参碱联合治疗组,32例。分别进行治疗,比较不同治疗方法的乙肝患者转阴率。结果阿德福韦酯与苦参碱联合治疗组在2个月、4个月和6个月治疗后的转阴率极显著高于另外两组(P<0.01),6个月治疗的转阴率达到72.3%。结论阿德福韦酯与苦参碱联合治疗乙肝治疗效果较好,具有较好的临床应用价值,值得推广。

Objective To investigate the united matrine adefovir dipivoxil treatment of patients with hepatitis B treatment effect. Methods Case patients were randomly divided into three groups, one group adefovir dipivoxil alone treatment group ,32 cases, the second group of matrine treatment group ,32 cases , three adefovir dipivoxil group with the united matrine treatment group ,32 eases. Treated separately to compare different treatments in patients with the negative rate. Results Adefovir dipivoxil with matrine treatment group at united in february, april and june of the negative rate after treatment was significantly higher than the other two group （P〈0.01） ,6 months of treatment the negative rate of 72.3%. Conclusion The united adefovir dipivoxil with matrine treatment of hepatitis B treatment is better,has better clinical value,you can promote.